NO2006005I1 - Difteri-,tetanus-, acellulære kikhoste- og polioantigener - Google Patents

Difteri-,tetanus-, acellulære kikhoste- og polioantigener

Info

Publication number
NO2006005I1
NO2006005I1 NO2006005C NO2006005C NO2006005I1 NO 2006005 I1 NO2006005 I1 NO 2006005I1 NO 2006005 C NO2006005 C NO 2006005C NO 2006005 C NO2006005 C NO 2006005C NO 2006005 I1 NO2006005 I1 NO 2006005I1
Authority
NO
Norway
Prior art keywords
tetanus
diphtheria
whooping cough
polio antigens
acellular whooping
Prior art date
Application number
NO2006005C
Other languages
English (en)
Other versions
NO2006005I2 (no
Original Assignee
Glaxosmithkline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline filed Critical Glaxosmithkline
Publication of NO2006005I1 publication Critical patent/NO2006005I1/no
Publication of NO2006005I2 publication Critical patent/NO2006005I2/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO2006005C 1996-11-07 2006-04-25 Difteri-,tetanus-, acellulære kikhoste- og polioantigener NO2006005I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition
PCT/EP1997/006180 WO1998019702A1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids

Publications (2)

Publication Number Publication Date
NO2006005I1 true NO2006005I1 (no) 2006-05-08
NO2006005I2 NO2006005I2 (no) 2010-04-12

Family

ID=10802615

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19992156A NO320186B1 (no) 1996-11-07 1999-05-04 Vaksinesammensetning omfattende difteri-, tetanus- og acellulaere kikhosteantigener, og anvendelse av denne for fremstilling av et medikament for behandling og forebyggelse av Bordetella pertussis infeksjoner.
NO2006005C NO2006005I2 (no) 1996-11-07 2006-04-25 Difteri-,tetanus-, acellulære kikhoste- og polioantigener

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19992156A NO320186B1 (no) 1996-11-07 1999-05-04 Vaksinesammensetning omfattende difteri-, tetanus- og acellulaere kikhosteantigener, og anvendelse av denne for fremstilling av et medikament for behandling og forebyggelse av Bordetella pertussis infeksjoner.

Country Status (30)

Country Link
EP (2) EP0941117B1 (no)
JP (1) JP3980652B2 (no)
KR (1) KR100518044B1 (no)
CN (1) CN1130226C (no)
AR (1) AR011509A1 (no)
AT (2) ATE295178T1 (no)
AU (1) AU710475B2 (no)
BR (2) BR9712917A (no)
CA (1) CA2271008C (no)
CO (1) CO4910171A1 (no)
CY (2) CY2407B1 (no)
CZ (1) CZ295954B6 (no)
DE (3) DE69733285T3 (no)
DK (2) DK0941117T3 (no)
ES (2) ES2240647T7 (no)
GB (1) GB9623233D0 (no)
HK (2) HK1022638A1 (no)
HU (1) HU224126B1 (no)
IL (1) IL129530A (no)
LU (1) LU91183I2 (no)
NO (2) NO320186B1 (no)
NZ (1) NZ335384A (no)
PL (1) PL188460B1 (no)
PT (2) PT941117E (no)
SA (1) SA98181128B1 (no)
SI (2) SI0941117T1 (no)
TR (1) TR199900979T2 (no)
TW (1) TW471971B (no)
WO (1) WO1998019702A1 (no)
ZA (1) ZA979984B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (fr) * 1998-11-26 2000-05-31 Pasteur Merieux MSD Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
ES2458355T3 (es) 2010-09-01 2014-05-05 Novartis Ag Adsorción de inmunopotenciadores sobre sales metálicas insolubles
BR112013022397A2 (pt) 2011-03-02 2017-09-26 Derek O’Hagan vacinas combinadas com doses menores de antígeno e/ou adjuvante
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
AU2013229432A1 (en) * 2012-03-08 2014-10-16 Novartis Ag Adjuvanted formulations of booster vaccines
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2013301312A1 (en) 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
ES2597832T3 (es) 2013-03-08 2017-01-23 Janssen Vaccines & Prevention B.V. Vacuna acelular contra la tosferina
AU2014304545A1 (en) 2013-08-05 2016-02-25 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
AP56A (en) 1987-01-30 1989-09-26 Smithkline Biologicals S A Hepatitis B virus surface antigens and hybrid antigehs containing them.
EP0304578B1 (en) 1987-06-22 2001-10-24 Medeva Holdings Bv Peptide comprising hepatitis B surface antigen
ES2056799T3 (es) 1987-07-17 1994-10-16 Rhein Biotech Ges Fur Biotechn Moleculas de adn codante para las regiones de control fmdh y gen estructural para una proteina que tiene una actividad de fmdh y su uso.
SG48175A1 (en) 1989-07-25 1998-04-17 Smithkline Beecham Biolog Novel antigens and method for their preparation
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
ES2118963T3 (es) 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.

Also Published As

Publication number Publication date
DE69733285T2 (de) 2006-01-12
NO320186B1 (no) 2005-11-07
DE122005000046I1 (de) 2005-12-29
DE69733285T3 (de) 2010-03-25
NO992156L (no) 1999-05-04
ATE295178T1 (de) 2005-05-15
SI1240905T1 (en) 2005-10-31
DK0941117T3 (da) 2002-11-18
HK1050473B (zh) 2006-03-03
HUP9904287A3 (en) 2001-05-28
CZ295954B6 (cs) 2005-12-14
GB9623233D0 (en) 1997-01-08
HU224126B1 (hu) 2005-05-30
ES2240647T7 (es) 2010-03-31
CA2271008A1 (en) 1998-05-14
HK1050473A1 (en) 2003-06-27
JP3980652B2 (ja) 2007-09-26
IL129530A0 (en) 2000-02-29
SA98181128B1 (ar) 2006-03-25
DK1240905T5 (da) 2010-01-11
AU710475B2 (en) 1999-09-23
SI0941117T1 (en) 2002-12-31
PL333127A1 (en) 1999-11-22
CN1130226C (zh) 2003-12-10
ES2240647T3 (es) 2005-10-16
DK1240905T3 (da) 2005-07-18
LU91183I2 (fr) 2005-09-20
TW471971B (en) 2002-01-11
DE69715031D1 (de) 2002-10-02
JP2001503422A (ja) 2001-03-13
KR20000053092A (ko) 2000-08-25
HUP9904287A1 (hu) 2000-04-28
CY2407B1 (en) 2004-09-10
EP1240905B1 (en) 2005-05-11
WO1998019702A1 (en) 1998-05-14
DE69715031T2 (de) 2003-05-08
CZ164099A3 (cs) 1999-10-13
CY2568B1 (en) 2008-07-02
ZA979984B (en) 1998-07-23
EP1240905B3 (en) 2009-08-26
CO4910171A1 (es) 2000-04-24
EP1240905A1 (en) 2002-09-18
NO992156D0 (no) 1999-05-04
BR9712917A (pt) 1999-12-07
BRPI9712917B8 (pt) 2021-05-25
CN1236321A (zh) 1999-11-24
PT1240905E (pt) 2005-09-30
AR011509A1 (es) 2000-08-30
KR100518044B1 (ko) 2005-09-30
IL129530A (en) 2005-11-20
BRPI9712917B1 (pt) 2019-12-03
HK1022638A1 (en) 2000-08-18
AU5319698A (en) 1998-05-29
TR199900979T2 (xx) 1999-07-21
DE69733285D1 (de) 2005-06-16
PL188460B1 (pl) 2005-02-28
PT941117E (pt) 2002-12-31
ES2182131T3 (es) 2003-03-01
NZ335384A (en) 2000-10-27
CA2271008C (en) 2008-07-22
EP0941117A1 (en) 1999-09-15
ATE222773T1 (de) 2002-09-15
EP0941117B1 (en) 2002-08-28
NO2006005I2 (no) 2010-04-12

Similar Documents

Publication Publication Date Title
NO2006005I2 (no) Difteri-,tetanus-, acellulære kikhoste- og polioantigener
NO20026175D0 (no) Vaksinesammensetning
EP0845270A4 (en) FUNCTIONAL FRAGMENT ANTIGEN OF TETANUS TOXIN, AND TETANUS VACCINE
ATE188508T1 (de) Impfstoffe gegen diphtherietoxin
ATE339965T1 (de) Vielwertige dtp-polio-impfstoffe
WO1998058668A3 (en) Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae
EP1309602A4 (en) MALARIA IMMUNOGEN AND VACCINE
KR970704468A (ko) 폴리에피토프 백신(polyepitope vaccines)
ZA200207002B (en) Salmonella vaccine materials and methods.
IL149471A0 (en) Vaccines for mycoplasma bovis and methods for immunizing bovine amimals
AU2001269569A1 (en) Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis surface antigen, and preparation method thereof
IL115521A0 (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
DK1027895T3 (da) Erysipelothrix rhusiopathiae-antigener og vaccinepræparater
ID20908A (id) Antigen fragmen fungsional toksin tetanus dan vaksin tetanus
BR1100913A (pt) Vacinas combinadas compreendendo o antìgeno superficial da hepatite b e outros antìgenos
ZA200301175B (en) Malaria immunogen and vaccine.
GB9603322D0 (en) Viral preparations,immunogens and vaccines